Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Wockhardt Ltd Regulatory Filings 2021

May 31, 2021

59231_rns_2021-05-31_565ed7f5-aac7-4dc1-ae86-1f9bacd84104.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

31[st] May, 2021

==> picture [167 x 46] intentionally omitted <==

To, National Stock Exchange of India Limited, Exchange Plaza, Block G, Plot C 1, Bandra Kurla Complex, Bandra East, Mumbai 400051

Kind Attn: Shri Sareesh Koroth, Chief Manager - Surveillance

Dear Sir,

This is with reference to your letter Ref. NSE/CM/Surveillance/10788 dated 28th May, 2021 advising us to provide Clarification /Confirmation on news item appearing in “Media/Publication”.

In this regards, please find below point wise reply to the clarification/information sought by you:

1. Whether such negotiations/events were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order from the start - of negotiations/events till date :

The Company is in the process of negotiating manufacturing options for Covid -19 vaccine with global Vaccine developers as part of its normal pharmaceutical business . Since such agreements needs technological evaluations, the Company is presently doing the same. It is also pertinent to note that such technical / commercial evaluations are meant to address the impact of global pandemic owing to Covid-19 and to the best interest of human race.

2. Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the movement in the trading, if any? Further, you are advised to provide the said information and the reasons for not disclosing the same to the Exchange earlier as required under regulation 30 of the SEBI (LODR) Regulations, 2015 announcement :-

Since the relevant agreements are not yet fully finalised, the same has not been informed to the Stock exchanges.

3. The material impact of this article on the Company :-

The Company has not finalised commercial agreements with the party. After finalising the agreement amount will be determined.

The Company has always in the past submitted information, time to time, as required by the relevant statutes and is also committed to do so in future.

Thanking you and assuring you of our cooperation at all the time.

For Wockhardt Limited

==> picture [114 x 42] intentionally omitted <==

Gajanand Sahu Company Secretary

==> picture [105 x 46] intentionally omitted <==

==> picture [483 x 30] intentionally omitted <==